Pharmabiz16d
Lupin receives US FDA tentative approval for loteprednol etabonate ophthalmic gel
Loteprednol etabonate ophthalmic gel, 0.38% (Lotemax SM) had an estimated annual sale of USD 36 million in the US (IQVIA MAT November 2024).
Drug Store News11d
FDA gives Lupin tentative OK for 2 generics
The Food and Drug Administration has given Lupin a tentative nod for two new generics. The first medication is loteprednol etabonate ophthalmic gel, 0.38%, which is a generic of Bausch & Lomb’s ...
The Financial Express16d
USFDA gives nod to Lupin’s generic formulation to treat eye issues
Loteprednol Etabonate Ophthalmic Gel, 0.38% (RLD Lotemax SM) had an estimated annual sale of USD 36 million in the U.S. (IQVIA MAT November 2024) ...